Biomarkers indicating oxidative stress (myeloperoxidase (MPO), Figure 4a) and overall organ stress (myoglobin, MMP-9, SAA; Figure 4b–d) as well as organ-specific markers for kidney (neutrophil gelatinase-associated lipocalin (NGAL), Cystatin C; Figure 4e,f) and endothelial (ICAM-1, VCAM-1; Figure 4g,h) damage were significantly increased in COVID-19 patients in general, but most pronounced in severe COVID-19 patients. This evidence concerns the gene LCN2 and COVID-19.